How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is Available
- PMID: 33639622
- PMCID: PMC7989578
- DOI: 10.1093/cid/ciab182
How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is Available
Abstract
Although vaccines against severe acute respiratory syndrome coronavirus 2 have now been found safe and efficacious, there remains an urgent global health need to test both these vaccines and additional vaccines against the same virus. Under variable conditions, either standard or unusual designs would for both familiar and often-missed reasons make continued testing possible and ethical.
Keywords: COVID-19 vaccine; ethics; randomized controlled trials as topic.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
References
-
- WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation. Placebo-controlled trials of covid-19 vaccines—why we still need them. N Engl J Med 2020; 384: e2. - PubMed
-
- Rid A, Lipsitch M, Miller FG. The ethics of continuing placebo in SARS-CoV-2 vaccine trials. JAMA 202. 1; 325:219-20. - PubMed
-
- Monrad JT. Ethical considerations for epidemic vaccine trials. J Med Ethics 2020: 46:465–9. - PubMed
-
- Cohen J. Early approval of a COVID-19 vaccine could stymie the hunt for better ones. Science 2020; 370:389–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
